Skip to main content
. 2013 Jan 28;19(4):463–481. doi: 10.3748/wjg.v19.i4.463

Table 4.

Main adverse events related to sedation occurring during endoscopy in clinical trials

Ref. Drug regimen Percentage of side effects Severe hypotension (< 60 mmHg) Severe desaturation (< 90%)
Ljubicić et al[98] Propofol 17.3% (including bradycardia: 11.8%) 5.5%
Conigliaro et al[95] Midazolam 0.47%
Gasparović et al[28] Propofol 2.9% 0.5% 2.4%
Sharma et al[97] Cardiopulmonary events EGD: 0.6%; Colonoscopy: 1.1%;ERCP: 2.1%; EUS: 0.9%
Nayar et al[96] Propofol deep sedation vs moderate sedation 0.6% vs 1.0% 0.1% 0.1% (apnoea: 0.3%)
Correia et al[69] Midazolam plus propofol vs midazolam plus fentanyl 14% vs 7.3%
Amornyotin et al[87] Diluted vs undiluted propofol for deep sedation 18.2% vs 42.9% 11.4% vs 31.0% 0 vs 2.4%
Wang et al[32] Midazolam vs midazolam combined with either fentanyl or propofol Midazolam combined with propofol resulted in hypotension and bradycardia more significantly than a combination with fentanyl or midazolam alone

EUS: Endoscopic Ultrasound; EGD: Esophagogastroduodenoscopy; ERCP: Endoscopic retrograde cholangiopancreatography.